Brief: Oncolytics Biotech Announces Publication Of Preclinical Data On Pelareorep Combined With Car T Cell Therapy
14/04/2022 12:04
April 14 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® ANNOUNCES PUBLICATION OF PRECLINICAL
DATA
DEMONSTRATING THE SYNERGISTIC ANTI-CANCER ACTIVITY OF PELAREOREP
COMBINED WITH CAR T CELL THERAPY IN SOLID TUMORS IN SCIENCE
TRANSLATIONAL MEDICINE
Source text for Eikon: ID:nCNWCHTmWa
Further company coverage: ONC.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer